Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Intellia Therapeutics Inc (NASDAQ: NTLA) was $23.28 for the day, up 2.42% from the previous closing price of $22.73. In other words, the price has increased by $2.42 from its previous closing price. On the day, 1.35 million shares were traded. NTLA stock price reached its highest trading level at $23.395 during the session, while it also had its lowest trading level at $22.11.
Ratios:
Our analysis of NTLA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.03 and its Current Ratio is at 9.03. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 23, 2024, Downgraded its rating to Neutral and sets its target price to $32 from $136 previously.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $66.Canaccord Genuity initiated its Buy rating on April 13, 2023, with a $66 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 04 ’24 when BASTA JAMES sold 2,297 shares for $32.99 per share. The transaction valued at 75,778 led to the insider holds 81,571 shares of the business.
Clark Eliana sold 605 shares of NTLA for $19,959 on Mar 04 ’24. The EVP, Chief Technical Officer now owns 71,470 shares after completing the transaction at $32.99 per share. On Jan 08 ’24, another insider, Sepp-Lorenzino Laura, who serves as the EVP, Chief Scientific Officer of the company, sold 2,275 shares for $28.87 each. As a result, the insider received 65,682 and left with 43,927 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NTLA now has a Market Capitalization of 2245947392 and an Enterprise Value of 1565516800. For the stock, the TTM Price-to-Sale (P/S) ratio is 42.70 while its Price-to-Book (P/B) ratio in mrq is 2.16. Its current Enterprise Value per Revenue stands at 29.76 whereas that against EBITDA is -3.082.
Stock Price History:
Over the past 52 weeks, NTLA has reached a high of $47.48, while it has fallen to a 52-week low of $19.37. The 50-Day Moving Average of the stock is -2.00%, while the 200-Day Moving Average is calculated to be -17.34%.
Shares Statistics:
NTLA traded an average of 1.41M shares per day over the past three months and 2208280 shares per day over the past ten days. A total of 96.48M shares are outstanding, with a floating share count of 94.66M. Insiders hold about 1.88% of the company’s shares, while institutions hold 91.42% stake in the company. Shares short for NTLA as of 1715731200 were 15167458 with a Short Ratio of 10.76, compared to 1713139200 on 14590490. Therefore, it implies a Short% of Shares Outstanding of 15167458 and a Short% of Float of 18.049999.
